Creative Medical Technology Holdings Inc (CELZ)

NASDAQ

Currency in USD

2.450

+0.050(+2.08%)

Closed06/12

After Hours

2.430-0.020(-0.816%)

06/12

Fair Value

Day's Range

2.260

2.540

52 wk Range

2.210

10.281

Creative Medical Tech Holdings (CELZ) Income Statement & Profits

Assess the Creative Medical Tech Holdings Income Statement (earnings report), showing the company's financial performance from operating and non operating activities such as revenue, expenses and income. Check assets and liabilities, diluted earnings per share (EPS), and net income after taxes for the last 4 periods (either quarterly or annually).

Investors who need greater depth or who want to customise how data is presented to fit their own investment styles are able to do so via their very own InvestingPro account.

Advanced Income Statement

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

0.09

0.09

0.01

Total Revenues Growth

-46.65%

+0.96%

-89.84%

Cost Of Revenues

0.05

0.03

0

Gross Profit

0.04

0.06

0.01

Gross Profit Growth

-65.05%

+51.01%

-91.02%

Gross Profit Margin %

45.36%

67.84%

60%

Other Operating Expenses, Total

3.17

10.3

5.63

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+157.64%	+225.5%	-45.41%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	0.11	6.27	1.97
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	2.96	3.94	3.56
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-

Operating Income

-3.13

-10.24

-5.62

Operating Income Growth

-180.4%

-227.72%

+45.14%

EBIT Margin %

-3,562.17%

-11,562.5%

-62,445.91%

Net Interest Expenses

-4.28

0.1

0.33

Net Interest Expenses Growth

-247.96%

+102.34%

+232.47%

Interest Expense, Total

-4.28

-

-

Interest And Investment Income

-

0.1

0.33

Other Non Operating Expenses, Total

26.03

-

-

EBT, Excl. Unusual Items

18.63

-10.14

-5.29

Gain (Loss) On Sale Of Assets

-

-

-

Other Unusual Items, Total

0.59

-

-

EBT, Incl. Unusual Items

19.21

-10.14

-5.29

EBT, Incl. Unusual Items Growth

+152.89%

-152.8%

+47.88%

EBT, Incl. Unusual Items Margin

21,892.75%

-11,449.26%

-58,739.71%

Income Tax Expense

-

-

-

Net Income to Company

19.21

-10.14

-5.29

Minority Interest

-

-

-

Net Income

19.21

-10.14

-5.29

Net Income Growth

+152.89%

-152.8%

+47.88%

Net Income Margin %

21,892.75%

-11,449.26%

-58,739.71%

Preferred Dividend and Other Adjustments

-

-

-

Net Income to Common Excl. Extra Items

19.21

-10.14

-5.29

Basic EPS - Continuing Operations

73.75

-9.28

-3.76

Basic EPS - Continuing Operations Growth

+111.76%

-112.58%

+59.53%

Diluted EPS - Continuing Operations

56.1

-9.28

-3.76

Diluted EPS - Continuing Operations Growth

+108.95%

-116.54%

+59.53%

Basic Weighted Average Shares Outstanding

0.26

1.09

1.41

Diluted Weighted Average Shares Outstanding

0.32

1.09

1.41

Dividend Per Share

-

-

-

Dividend Per Share Growth

-

-

-

EBITDA

-3.03

-10.15

-5.53

EBITDA Growth

-189.48%

-234.63%

+45.57%

EBITDA Margin %

-3,457.24%

-11,458.56%

-61,394.98%

EBIT